SHAREHOLDER NOTICE: Kaskela Law LLC Announces Shareholder Complaint Filed Against M.D.C. Holdings, Inc. (MDC) and Encourages Investors to Contact the Firm

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC announces that a shareholder complaint has been filed against M.D.C. Holdings, Inc. (NYSE: MDC) (“MDC”) in connection with the recently announced buyout of the company’s shareholders.

On January 18, 2024, MDC announced that it had agreed to be acquired by Sekisui House, Ltd. (“Sekisui”) at a price of $63.00 per share in cash – a less than 20% premium to the prior day’s closing price. Following the closing of the proposed transaction, MDC’s stockholders will be cashed out of their investment position and the company’s shares will no longer be publicly traded.

According to the complaint, MDC has filed a materially deficient proxy statement in connection with the above proposed transaction, which “deprives [investors] of the information necessary to make an intelligent, informed and rational decision of whether to vote in favor of the proposed transaction.”

Kaskela Law is investigating whether MDC shareholders are receiving sufficient consideration for their shares, and whether MDC’s officers and/or directors breached their fiduciary duties or violated the securities laws in agreeing to sell the company to Sekisui at $63.00 per share.

MDC shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750, or by email ([e-mail] / [e-mail]) or online at https://kaskelalaw.com/cases/m-d-c-holdings/, for additional information about this investigation and their legal rights and options with respect to this transaction.

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation on a contingent basis. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.

This notice may constitute attorney advertising in certain jurisdictions.